telmisartan and AIDS Seroconversion
telmisartan has been researched along with AIDS Seroconversion in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hampson, LV; Jaki, T | 1 |
De Caterina, R; Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J | 1 |
Other Studies
2 other study(ies) available for telmisartan and AIDS Seroconversion
Article | Year |
---|---|
Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials, Phase III as Topic; Computer Simulation; Decision Making; Endpoint Determination; HIV Seropositivity; Humans; Insulin Resistance; Models, Statistical; Patient Safety; Research Design; Sample Size; Telmisartan | 2016 |
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cystatin C; Endothelin-1; HIV Seropositivity; Humans; Hypertension; Insulin Resistance; Interleukin-18; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; PPAR gamma; Risk Factors; Telmisartan; Triglycerides | 2011 |